Analysts’ Upgrades for August 13th (AOS, AVIR, BPT, CPH, DCO, DELL, EDAP, ENLC, FR, GCO)

Analysts’ upgrades for Tuesday, August 13th:

A. O. Smith (NYSE:AOS) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Atea Pharmaceuticals (NASDAQ:AVIR) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating. They currently have $6.88 price target on the stock, up from their previous price target of $2.00.

Bridgepoint Group (LON:BPT) was upgraded by analysts at JPMorgan Chase & Co. to an overweight rating. JPMorgan Chase & Co. currently has GBX 358 ($4.57) target price on the stock, up from their previous target price of GBX 259 ($3.31).

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. The firm currently has C$16.00 price target on the stock, up from their previous price target of C$9.50.

Ducommun (NYSE:DCO) was upgraded by analysts at The Goldman Sachs Group, Inc. from a neutral rating to a buy rating. The Goldman Sachs Group, Inc. currently has $80.00 target price on the stock, up from their previous target price of $64.00.

Dell Technologies (NYSE:DELL) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. They currently have $97.00 target price on the stock.

Edap Tms (NASDAQ:EDAP) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

EnLink Midstream (NYSE:ENLC) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

First Industrial Realty Trust (NYSE:FR) was upgraded by analysts at Wolfe Research from a peer perform rating to an outperform rating. They currently have $64.00 target price on the stock.

Genesco (NYSE:GCO) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Generac (NYSE:GNRC) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Knight Therapeutics (TSE:GUD) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. They currently have C$6.75 target price on the stock, up from their previous target price of C$5.75.

Hormel Foods (NYSE:HRL) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. The firm currently has $37.00 price target on the stock, up from their previous price target of $33.00.

Immunic (NASDAQ:IMUX) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Inogen (NASDAQ:INGN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Eastman Kodak (NYSE:KODK) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Littelfuse (NASDAQ:LFUS) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. Stifel Nicolaus currently has $280.00 target price on the stock, up from their previous target price of $270.00.

Alliant Energy (NASDAQ:LNT) was upgraded by analysts at LADENBURG THALM/SH SH from a neutral rating to a buy rating. LADENBURG THALM/SH SH currently has $62.50 price target on the stock, up from their previous price target of $50.00.

AG Mortgage Investment Trust (NYSE:MITT) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

New Jersey Resources (NYSE:NJR) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Odyssey Marine Exploration (NASDAQ:OMEX) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Starbucks (NASDAQ:SBUX) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. Robert W. Baird currently has $110.00 price target on the stock, up from their previous price target of $81.00.

Starbucks (NASDAQ:SBUX) was upgraded by analysts at Piper Sandler from a neutral rating to an overweight rating. The firm currently has $103.00 price target on the stock, up from their previous price target of $85.00.

Starbucks (NASDAQ:SBUX) was upgraded by analysts at TD Cowen from a hold rating to a buy rating. They currently have $105.00 target price on the stock, up from their previous target price of $81.00.

ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating. Raymond James currently has $22.00 price target on the stock, up from their previous price target of $18.00.

STERIS (NYSE:STE) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Toll Brothers (NYSE:TOL) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

LendingTree (NASDAQ:TREE) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

UMH Properties (NYSE:UMH) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

UnitedHealth Group (NYSE:UNH) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Vodafone Group Public (NASDAQ:VOD) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Receive News & Ratings for A O Smith Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for A O Smith Co and related companies with MarketBeat.com's FREE daily email newsletter.